A Clinical Risk Model for Personalized Screening and Prevention of Breast Cancer

被引:5
|
作者
Eriksson, Mikael [1 ,2 ]
Czene, Kamila [1 ]
Vachon, Celine [3 ]
Conant, Emily F. [4 ]
Hall, Per [1 ,5 ]
机构
[1] Karolinska Inst, Dept Med Epidemiol & Biostat, S-17165 Stockholm, Sweden
[2] Univ Cambridge, Ctr Canc Genet Epidemiol, Dept Publ Hlth & Primary Care, Cambridge CB1 8RN, England
[3] Mayo Clin, Coll Med, Dept Quantitat Hlth Sci, Div Epidemiol, Rochester, MN 55905 USA
[4] Univ Penn, Perelman Sch Med, Dept Radiol, Philadelphia, PA 19104 USA
[5] Sodersjukhuset Univ Hosp, Dept Oncol, S-11883 Stockholm, Sweden
关键词
breast cancer; risk model; long-term risk; primary prevention; individualized screening; artificial intelligence; image-derived risk model; FOLLOW-UP; TAMOXIFEN; WOMEN;
D O I
10.3390/cancers15123246
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
Simple Summary We investigated the benefits of adding lifestyle and familial risk factors to a mammographic image-derived short-term AI risk model in a 10-year follow-up study for its potential use in personalized screening and prevention of breast cancer (BC). In a case-cohort study, 8110 women were selected from women aged 40-74 participating in a Swedish mammography screening cohort. The women had no BC diagnosis at enrollment. In all, 1661 incident BCs were developed in the case-cohort. The lifestyle/familial-expanded AI risk model showed a significantly higher discriminatory performance in the long term and short term than the imaging-only risk model and the clinical Tyrer-Cuzick v8 model. The expanded model also showed the highest risk classification performance using positive predictive value (PPV). The results suggest that a lifestyle/familial-expanded image-derived AI risk model could most efficiently refine the identification of women who may benefit from personalized screening and/or risk-reducing intervention. Background: Image-derived artificial intelligence (AI) risk models have shown promise in identifying high-risk women in the short term. The long-term performance of image-derived risk models expanded with clinical factors has not been investigated. Methods: We performed a case-cohort study of 8110 women aged 40-74 randomly selected from a Swedish mammography screening cohort initiated in 2010 together with 1661 incident BCs diagnosed before January 2022. The imaging-only AI risk model extracted mammographic features and age at screening. Additional lifestyle/familial risk factors were incorporated into the lifestyle/familial-expanded AI model. Absolute risks were calculated using the two models and the clinical Tyrer-Cuzick v8 model. Age-adjusted model performances were compared across the 10-year follow-up. Results: The AUCs of the lifestyle/familial-expanded AI risk model ranged from 0.75 (95%CI: 0.70-0.80) to 0.68 (95%CI: 0.66-0.69) 1-10 years after study entry. Corresponding AUCs were 0.72 (95%CI: 0.66-0.78) to 0.65 (95%CI: 0.63-0.66) for the imaging-only model and 0.62 (95%CI: 0.55-0.68) to 0.60 (95%CI: 0.58-0.61) for Tyrer-Cuzick v8. The increased performances were observed in multiple risk subgroups and cancer subtypes. Among the 5% of women at highest risk, the PPV was 5.8% using the lifestyle/familial-expanded model compared with 5.3% using the imaging-only model, p < 0.01, and 4.6% for Tyrer-Cuzick, p < 0.01. Conclusions: The lifestyle/familial-expanded AI risk model showed higher performance for both long-term and short-term risk assessment compared with imaging-only and Tyrer-Cuzick models.
引用
收藏
页数:23
相关论文
共 50 条
  • [31] Uptake of screening and prevention in women at very high risk of breast cancer
    Evans, DGR
    Lalloo, F
    Shenton, A
    Boggis, C
    Howell, A
    LANCET, 2001, 358 (9285): : 889 - 890
  • [32] The risk-based breast screening (RIBBS) study protocol: a personalized screening model for young women
    Gisella Gennaro
    Lauro Bucchi
    Alessandra Ravaioli
    Manuel Zorzi
    Fabio Falcini
    Francesca Russo
    Francesca Caumo
    La radiologia medica, 2024, 129 : 727 - 736
  • [33] Validation study results for a personalized prevention education aid in breast cancer risk reduction
    Wang, Tianyi
    Che, Mandy
    Huilgol, Yash
    Goodman, Deborah
    Keane, Holly
    Lee, Vivian
    Belkora, Jeff
    Fiscalini, Allison
    Esserman, Laura
    CANCER RESEARCH, 2021, 81 (04)
  • [34] The risk-based breast screening (RIBBS) study protocol: a personalized screening model for young women
    Gennaro, Gisella
    Bucchi, Lauro
    Ravaioli, Alessandra
    Zorzi, Manuel
    Falcini, Fabio
    Russo, Francesca
    Caumo, Francesca
    RADIOLOGIA MEDICA, 2024, 129 (05): : 727 - 736
  • [35] Genetic discrimination in insurance and employment based on personalized risk stratification for breast cancer screening
    Reveiz, Manuela
    Bouhouita-Guermech, Sarah
    Blackmore, Kristina M.
    Chiquette, Jocelyne
    Demers, Eric
    Dorval, Michel
    Lambert-Cote, Laurence
    Nabi, Hermann
    Pashayan, Nora
    Soucy, Penny
    Turgeon, Annie
    Walker, Meghan J.
    Knoppers, Bartha M.
    Chiarelli, Anna M.
    Simard, Jacques
    Joly, Yann
    FRONTIERS IN GENETICS, 2025, 16
  • [36] Towards personalized screening: Cumulative risk of breast cancer screening outcomes in women with and without a first-degree relative with a history of breast cancer
    Ripping, Theodora Maria
    Hubbard, Rebecca A.
    Otten, Johannes D. M.
    den Heeten, Gerard J.
    Verbeek, Andre L. M.
    Broeders, Mireille J. M.
    INTERNATIONAL JOURNAL OF CANCER, 2016, 138 (07) : 1619 - 1625
  • [37] Effect of cancer risk and patient preferences on net benefit of lung cancer screening: A Personalized Lung Cancer Screening Model
    Cao, Pianpian
    Caverly, Tanner
    Hayward, Rodney
    Meza, Rafael
    CANCER EPIDEMIOLOGY BIOMARKERS & PREVENTION, 2017, 26 (05)
  • [38] Personalized Medicine Through SNP Testing for Breast Cancer Risk: Clinical Implementation
    Howe, Rebecca
    Miron-Shatz, Talya
    Hanoch, Yaniv
    Omer, Zehra B.
    O'Donoghue, Cristina
    Ozanne, Elissa M.
    JOURNAL OF GENETIC COUNSELING, 2015, 24 (05) : 744 - 751
  • [39] A Scoping Review of Personalized, Interactive, Web-Based Clinical Decision Tools Available for Breast Cancer Prevention and Screening in the United States
    Kamil, Dalya
    Wojcik, Kaitlyn M.
    Smith, Laney
    Zhang, Julia
    Wilson, Oliver W. A.
    Butera, Gisela
    Jayasekera, Jinani
    MDM POLICY & PRACTICE, 2024, 9 (01)
  • [40] PREVENTION AND SCREENING FOR BREAST-CANCER
    HARPER, GR
    ENGLISBE, BH
    CANCER DETECTION AND PREVENTION, 1993, 17 (4-5): : 551 - 555